11th IVHEM (Int. Viral Hepatitis Elimination Meeting)

We are delighted to announce that the 11th edition of the International Viral Hepatitis Elimination Meeting (IVHEM) will be held January 9^th and 10^th , 2025 in Seoul, South Korea.

IVHEM has moved to Asia to focus on the region of the worlds with the largest burdens of hepatitis virus transmission and disease.

11^th IVHEM, provides the forum for clinical researchers, health officials and civil society  members to exchange data revealing the status of progress toward goals for Hepatitis B and Hepatitis C elimination, and share research findings and lessons learned in providing equitable access to  hepatitis prevention, care and treatment services.  Through presentations and discussions, 11^th IVHEM will lead to a shared understanding of priorities for clinical research, service delivery and advocacy to overcome the remaining barriers

to the elimination of Hepatitis B and Hepatitis C as health threats. 

For this IVHEM, the Korean DCA (Korean Disease Control and Prevention Agency) will serve as co-host with Viral ED and the Coalition for Global Hepatitis Elimination.

Make sure to secure your space to contribute to the elimination of viral hepatitis and come and join this unique meeting with the field’s established experts and rising stars!

Sincerely,

Huma Qureshi, MD
John Ward, MD
11^th IVHEM Program Chairs

Add to Calendar

Contribute to Viral Hepatitis Elimination by Submitting an Abstract

With hepatitis B and C affecting more than 354 million people globally, continued research, innovation, and discussion is a critical component in meeting the 2030 elimination targets.

IVHEM provides you a unique, focused, and scientific setting to present your research and data to the field’s leading voices – hear their thoughts on your work and pose your questions to them!

New original data as well as encored abstracts are welcome in the following categories:

• Assessing Progress Towards Hepatitis Elimination

• Hepatitis Micro-Elimination Programs

• Key Populations

• Models for Care

• Monitoring and Testing

• Prevention

• Strategies to Move Forward to Come to Elimination

IVHEM accepts abstracts related to all viral hepatitis variants (HAV, HBV, HCV, HDV, and HEV) and coinfections and you can find the full guidelines on the meeting webpage.

Registration fees are waived for healthcare professionals from RLS and early-career professionals with an accepted abstract.